Sunshine Biopharma, Inc.
USD2.60
+0.20 (+8.56%)
CEO
Steve N. Slilaty
IPO Date
2022-02-15
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
CA
Open
$2.90
Prev. Close
$2.40
Day Low
$2.46
Day High
$3.05
52W Low
$2.11
52W High
$24.30
Market Cap
$0.00B
Volume
13.15M
| 100,000 |
| $0.10 |
| 12 Feb 2024 | Slilaty Steve N. | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 20,000 | $0.10 |
| 2 Dec 2022 | Sebaaly Camille | CFO/Secretary | P-Purchase | Acquired | 30,000 | $0.76 |
| 6 Jun 2022 | Sebaaly Camille | CFO/Secretary | P-Purchase | Acquired | 25,000 | $1.22 |
| 22 Feb 2022 | Slilaty Steve N. | director, officer: Chief Executive Officer | D-Return | Disposed | 990,000 | $0.10 |
| 16 Feb 2021 | Slilaty Steve N. | director, officer: Chief Executive Officer | A-Award | Acquired | 20,000,000 | $0.00 |
| 16 Feb 2021 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 20,000,000 | $0.00 |
| 16 Feb 2021 | MERZOUKI ABDERRAZZAK | director, officer: Chief Operating Officer | A-Award | Acquired | 20,000,000 | $0.00 |
| 15 Jul 2020 | Sebaaly Camille | director, officer: CFO/Secretary | A-Award | Acquired | 1,300,000 | $0.00 |